JAMES, page-10

First 10 Last

Share
Profile

Follow
cane7

4,133 Posts.

275

10/07/21

13:13

Post #: 54414249
Share

Originally posted by tinhat: ↑

We don't need this sort of shit talk on KZA board with all due respect. As mentioned above, The Beard has been out there selling the Kazia story and he has told the market everything there is to know about paxsalisib and talked up its potential ad nauseam. The clinical trial data newsflow calendar is out there and is known by all investors. You jumped the gun in June when you asked why there was no 2HCY news and we are only ten days into the 2HCY ffs.

The HC boards are just full of whining and melodramatic carry on across so many speculative pre-profit stocks that I am in. These stocks are going to be in for a rough ride for a while as macro-economic monetary conditions see the flow of money back into bonds and less speculative "value" stocks. I can understand the fear of young hot-money job-keeper, super withdrawal, diamond hands stonk speculators who are now coming to understand that stock prices go both up and down on speculation. You don't have that excuse.

KZA is stuck in a sideways trend of trading. Every day/week the share price is going to go up and down. There might even be a market correction just around the corner that will throw a spanner in the works. Maybe we drop 30% next week on the back of a market downturn. Who knows. Nothing a seasoned investor cannot handle.

Look, we've all had to live through the angst of seemingly ill timed capital raises. That is par for the course in pre-profit spec stocks it seems. But otherwise, what The Beard has achieved in terms of the progressing of Paxsalisib through clinical trials, for the money we have spent, is brilliant. The fact that the progression free survival data read outs for our phase II study are delayed is something any sensible investor should be extremely pleased about. Oh, yeah, that's right, we just got an update about that in the past week or so, didn't we?

Furthermore, the man displays a handsomely manicured hirsuteness that I admire.

Expand

Yes i drink too much,, bye bye all.

KZA Price at posting: $1.33 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

HLX

Helix investor makes partial takeover bid, proposing board changes